Pemphigus Foliaceous after COVID-19 Infection and Bamlanivimab Infusion
Keyword(s):
We report a case of pemphigus foliaceous (PF) in the setting of bamlanivimab, a novel monoclonal antibody for the treatment of COVID-19. PF is a rare autoimmune blistering disease caused by autoantibodies directed against desmoglein-1 (DSG1). Drugs and viruses have been implicated as inciting factors of pemphigus in predisposed patients. Given the current pandemic, the presentation of PF following COVID-19 infection and bamlanivimab infusion is of special interest and further investigation may be warranted.
2012 ◽
Vol 16
(2)
◽
pp. 128-130
◽
2016 ◽
Vol 13
(1)
◽
pp. 61-65
2017 ◽
Vol 18
(2)
◽
pp. 287-297
◽
Keyword(s):
2020 ◽
Vol 18
(1)
◽
pp. 24-27
Keyword(s):
2014 ◽
Vol 2014
◽
pp. 1-5
◽